US: NIH Begins Covid-19 Booster Clinical Trials in People with Autoimmune Disease
The NIH (National Institute of Health) of the United States has started a clinical trial for the purpose of assessing the response of the antibody to the novel corona virus booster vaccine in the people that have autoimmune disease, who does not respond to the first dose of the novel corona virus vaccine. The trial […]
Continue Reading